LSX: The Network For Life Science Executives.png
Martin Olovsson

Martin Olovsson

Martin cofounded OnDosis in 2017 based on a concept from AstraZeneca. He has solid experience from senior roles within the pharmaceutical industry across commercial and development at local, regional and global level. Martin has a past as Global lead for the Respiratory franchise in AstraZeneca and as CEO of the AstraZeneca Nordic-Baltic Region.
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Posts by Martin Olovsson

Martin Olovsson Martin Olovsson
April 10, 2019

OnDosis: Improving treatment by Integrating oral m...

Pharmaceutical innovation has accelerated, but the way of dosing oral medic...

Read More

Add Your Response

ABOUT THE BLOG

The LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.

CATEGORIES

see all

Subscribe Email

UPCOMING CONFERENCE
LSX 2020

UPCOMING CONFERENCE
Longevity 2020 Email Header 670x280 04
Popup Close

The 5th annual LSX World Congress is a high-calibre, senior executive, two-day conference and partnering event.
 
DOWNLOAD FULL AGENDA
ABOUT US

LSX is an influential community of senior life science decision makers.

We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

 
EVENTS

Longevity Leaders Conference

LSX Nordic Congress

LSX USA CEO Forums

Digihealth Leaders

Inv€$tival Showcase

European Lifestars Awards

LSX World Congress

Healthspan Show
LINKS

About

Partners

FAQs

Resources

Contact Us


© 2020 All Rights Reserved By LSX Ltd | Privacy Policy